Effect of age on outcomes after allogeneic disc tissue supplementation in patients with chronic discogenic low back pain in the VAST trial

 To explore the effects of viable allogeneic disc tissue supplementation in younger patients with discogenic chronic low back pain (CLBP). VAST was a randomized placebo-controlled trial of disc allograft supplementation in 218 patients with discogenic CLBP. We conducted a analysis of change from bas...

Full description

Saved in:
Bibliographic Details
Published in:Pain management (London) 2022-04, Vol.12 (3), p.301-311
Main Authors: Hunter, Corey W, Guyer, Richard, Froimson, Mark, DePalma, Michael J
Format: Article
Language:English
Subjects:
allogeneic disc tissue
allograft
degenerative disc disease
discogenic back pain
intradiscal therapy
low back pain
Oswestry Disability Index
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary: To explore the effects of viable allogeneic disc tissue supplementation in younger patients with discogenic chronic low back pain (CLBP). VAST was a randomized placebo-controlled trial of disc allograft supplementation in 218 patients with discogenic CLBP. We conducted a analysis of change from baseline to 12 months in Oswestry Disability Index (ODI) and visual analog scale for pain intensity scores stratified by patient age. Patients aged
ISSN:1758-1869
1758-1877
DOI:10.2217/pmt-2021-0078